These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1028 related items for PubMed ID: 16703718

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study.
    Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B.
    Am J Obstet Gynecol; 2004 Mar; 190(3):644-53. PubMed ID: 15041994
    [Abstract] [Full Text] [Related]

  • 28. Chronic vulvovaginal candidosis: the role of oral treatment.
    Merkus JM, Van Heusden AM.
    Br J Clin Pract Suppl; 1990 Sep; 71():81-4. PubMed ID: 1965421
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, Alberico S.
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Recurrent vulvovaginal candidiasis.
    MacNeill C, Carey JC.
    Curr Womens Health Rep; 2001 Aug; 1(1):31-5. PubMed ID: 12112949
    [Abstract] [Full Text] [Related]

  • 32. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
    Sobel JD.
    Obstet Gynecol; 1985 Mar; 65(3):435-40. PubMed ID: 3838374
    [Abstract] [Full Text] [Related]

  • 33. Candidiasis (vulvovaginal).
    Spence D.
    Clin Evid; 2005 Dec; (14):2200-15. PubMed ID: 16620487
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
    De Seta F, Schmidt M, Vu B, Essmann M, Larsen B.
    J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
    Sobel JD, Schmitt C, Stein G, Mummaw N, Christensen S, Meriwether C.
    J Reprod Med; 1994 Jul; 39(7):517-20. PubMed ID: 7966041
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Candidiasis (vulvovaginal).
    Spence D.
    Clin Evid; 2003 Dec; (10):2044-57. PubMed ID: 15555192
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 52.